AngioDynamics appoints Richard Rosenzweig general counsel 

AngioDynamics, a  provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced that it has appointed Richard C. Rosenzweig as Senior Vice President, General Counsel, effective January 31, 2021. Mr. Rosenzweig will also serve as Corporate Secretary to the AngioDynamics Board of Directors.

Mr. Rosenzweig succeeds Stephen Trowbridge who has served as Executive Vice President, Chief Financial Officer, and General Counsel since February 2020. Mr. Trowbridge will continue in his role as Executive Vice President and Chief Financial Officer.

He joins AngioDynamics from C.R. Bard, where he served as corporate officer and Vice President, Law and completed more than 75 business development transactions. Rosenzweig has more than 20 years of experience in leadership roles providing legal guidance, governance and compliance oversight, and strategic business leadership to global medical device and health care companies, including Phibro Animal Health Corporation, Impath, Inc., and Johnson & Johnson.

AngioDynamics appoints Richard Rosenzweig general counsel 

Leave a Reply

InhousecommunityUS.com

is the international magazine, in English, that covers legal and inhouse affairs in the United States, through experiences beyond Italy’s borders to reach overseas destinations and all over the world.

For more information, visit the Group’s website www.lcpublishinggroup.com

LC srl – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 10.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram